Tronox
TROX
3.75
+0.04
+0.94%
Tronox
US · TROX
#3635 by market cap
3.75
+0.04
+0.94%
Live - 5344 symbols - heartbeat 104s ago
· 2026-10-08 10:10
Pre-market
3.71
0.00%
After-hours
3.71
0.00%
Overnight
3.74
+0.81%
- Market cap
- 598.08M
- P/E (TTM)i
- -1.08
- P/Bi
- 0.52
- EPSi
- -2.97
- Div yieldi
- 5.34%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on TROX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.80, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.73% YoY
Margins
- Gross margin
- 9.28%
- Operating margin
- -0.72%
- Net margin
- -16.22%
Key ratios & quality
- Enterprise valuei
- 3.64B
- Altman Z-Scorei
- 0.80
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.82B | 2.64B | 2.76B | 3.57B | 3.45B | 2.85B | 3.07B | 2.90B |
| Gross profit | 498.00M | 464.00M | 621.00M | 895.00M | 832.00M | 462.00M | 515.00M | 269.00M |
| Selling & admin expenses | 267.00M | 347.00M | 347.00M | 318.00M | 289.00M | 276.00M | 296.00M | 290.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 231.00M | 117.00M | 274.00M | 577.00M | 543.00M | 186.00M | 219.00M | -21.00M |
| Pretax profit | 43.00M | -88.00M | 114.00M | 374.00M | 308.00M | 49.00M | 73.00M | -458.00M |
| Tax | 13.00M | 14.00M | -881.00M | 71.00M | -192.00M | 363.00M | 127.00M | 15.00M |
| Net profit | 30.00M | -97.00M | 995.00M | 303.00M | 500.00M | -314.00M | -54.00M | -473.00M |
| Basic EPS | 0 | -1 | 7 | 2 | 3 | -2 | 0 | -3 |
| Diluted EPS | -0.06 | -0.78 | 6.69 | 1.81 | 3.16 | -2.02 | -0.31 | -2.97 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 738.00M | 731.00M | 699.00M | 730.00M | 760.00M | 868.00M |
| Gross profit | 99.00M | 79.00M | 52.00M | 39.00M | 44.00M | 55.00M |
| Selling & admin expenses | 74.00M | 72.00M | 70.00M | 74.00M | 71.00M | 72.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 25.00M | 7.00M | -18.00M | -35.00M | -27.00M | -17.00M |
| Pretax profit | -106.00M | -81.00M | -92.00M | -179.00M | -104.00M | -67.00M |
| Tax | 5.00M | 4.00M | 8.00M | -2.00M | 0 | 106.00M |
| Net profit | -111.00M | -85.00M | -100.00M | -177.00M | -104.00M | -173.00M |
| Basic EPS | -1 | -1 | -1 | -1 | -1 | -1 |
| Diluted EPS | -0.70 | -0.53 | -0.63 | -1.11 | -0.65 | -1.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.54B | 2.07B | 2.53B | 2.05B | 1.96B | 2.14B | 2.16B | 2.27B |
| Cash & ST investments | 1.03B | 302.00M | 619.00M | 228.00M | 164.00M | 273.00M | 151.00M | 199.00M |
| Inventory | 479.00M | 1.13B | 1.14B | 1.05B | 1.28B | 1.42B | 1.55B | 1.65B |
| Total assets | 4.64B | 5.27B | 6.57B | 5.99B | 6.31B | 6.13B | 6.04B | 6.22B |
| Total current liabilities | 300.00M | 702.00M | 805.00M | 822.00M | 850.00M | 753.00M | 874.00M | 919.00M |
| Short-term debt | 22.00M | 76.00M | 97.00M | 44.00M | 94.00M | 62.00M | 124.00M | 112.00M |
| Long-term debt | 3.14B | 2.99B | 3.26B | 2.56B | 2.46B | 2.79B | 2.76B | 3.13B |
| Total liabilities | 3,780,000,000.00 | 4,352,000,000.00 | 4,697,000,000.00 | 3,945,000,000.00 | 3,903,000,000.00 | 4,154,000,000.00 | 4,247,000,000.00 | 4,768,000,000.00 |
| Total equity | 862.00M | 916.00M | 1.87B | 2.04B | 2.40B | 1.98B | 1.79B | 1.45B |
| Retained earnings | -357.00M | -493.00M | 434.00M | 663.00M | 1.08B | 684.00M | 555.00M | 30.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.19B | 2.24B | 2.31B | 2.27B | 2.17B | 2.14B |
| Cash & ST investments | 138.00M | 132.00M | 185.00M | 199.00M | 126.00M | 194.00M |
| Inventory | 1.61B | 1.69B | 1.69B | 1.65B | 1.58B | 1.46B |
| Total assets | 6.07B | 6.19B | 6.30B | 6.22B | 6.06B | 5.95B |
| Total current liabilities | 961.00M | 1.07B | 847.00M | 919.00M | 895.00M | 840.00M |
| Short-term debt | 244.00M | 329.00M | 124.00M | 112.00M | 194.00M | 140.00M |
| Long-term debt | 2.75B | 2.75B | 3.14B | 3.13B | 3.12B | 3.12B |
| Total liabilities | 4,363,000,000.00 | 4,507,000,000.00 | 4,710,000,000.00 | 4,768,000,000.00 | 4,736,000,000.00 | 4,759,000,000.00 |
| Total equity | 1.71B | 1.68B | 1.59B | 1.45B | 1.32B | 1.19B |
| Retained earnings | 425.00M | 321.00M | 213.00M | 30.00M | -73.00M | -244.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 170.00M | 441.00M | 355.00M | 740.00M | 598.00M | 184.00M | 300.00M | 60.00M |
| Depreciation & amortization | 195.00M | 280.00M | 304.00M | 297.00M | 269.00M | 275.00M | 285.00M | 302.00M |
| Free cash flow | 53.00M | 243.00M | 160.00M | 468.00M | 170.00M | -77.00M | -70.00M | -281.00M |
| Dividends paid | -23.00M | -27.00M | -40.00M | -65.00M | -87.00M | -89.00M | -80.00M | -48.00M |
| Stock buybacks / issuance | 0 | -288.00M | 0 | 0 | -50.00M | -- | -- | -- |
| Ending cash balance | 1.70B | 311.00M | 648.00M | 232.00M | 164.00M | 273.00M | 152.00M | 211.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -32.00M | 28.00M | -57.00M | 121.00M | -68.00M | 105.00M |
| Depreciation & amortization | 71.00M | 74.00M | 75.00M | 82.00M | 75.00M | 76.00M |
| Free cash flow | -142.00M | -55.00M | -137.00M | 53.00M | -135.00M | 60.00M |
| Dividends paid | 0 | -20.00M | -20.00M | -8.00M | -8.00M | -8.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 138.00M | 133.00M | 186.00M | 211.00M | 138.00M | 206.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -0.93 | -15.23 | 79.23 | 15.49 | 22.85 | -14.72 | -2.60 | -29.57 |
| ROA %i | -0.15 | -2.20 | 16.37 | 4.56 | 8.09 | -5.08 | -0.79 | -7.67 |
| ROIC %i | 2.49 | 0.64 | 24.38 | 8.18 | 12.04 | -4.29 | 1.41 | -7.01 |
| 5-year avg ROE %i | -17.09 | -15.70 | 5.20 | 9.51 | 20.28 | 17.52 | 20.05 | -1.71 |
| EBIT margin %i | 12.37 | 4.28 | 10.62 | 14.56 | 12.30 | 6.95 | 7.48 | -9.70 |
| FCF / sales %i | 2.91 | 9.20 | 5.80 | 13.10 | 4.92 | -- | -- | -- |
| Current ratioi | 8.48 | 2.95 | 3.14 | 2.49 | 2.31 | 2.84 | 2.47 | 2.46 |
| Quick ratioi | 4.51 | 1.13 | 1.44 | 1.05 | 0.64 | 0.76 | 0.48 | 0.53 |
| Debt / assetsi | 68.10 | 59.34 | 51.78 | 44.38 | 42.31 | 48.11 | 49.52 | 54.56 |
| LT debt / equityi | 459.59 | 407.75 | 194.58 | 131.04 | 109.21 | 149.23 | 162.75 | 231.31 |
| Interest coveragei | 1.24 | 0.56 | 1.64 | 3.56 | 3.63 | 1.33 | 1.46 | -1.59 |
| Revenue CAGR (3Y) %i | 6.40 | 26.38 | 17.55 | 25.23 | 9.34 | 1.10 | -4.88 | -5.68 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 0.64 | 25.14 | -4.03 | 106.69 | -11.23 | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -8.44 | -14.11 | -18.65 | -29.57 | -31.18 | -39.12 |
| ROA %i | -2.48 | -4.07 | -5.19 | -7.67 | -7.62 | -9.05 |
| ROIC %i | -0.67 | -2.67 | -4.01 | -7.01 | -7.40 | -9.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.02 | -0.37 | -3.45 | -9.70 | -9.18 | -7.95 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.28 | 2.10 | 2.72 | 2.46 | 2.42 | 2.55 |
| Quick ratioi | 0.48 | 0.40 | 0.58 | 0.53 | 0.51 | 0.66 |
| Debt / assetsi | 51.13 | 51.60 | 54.05 | 54.56 | 57.19 | 57.46 |
| LT debt / equityi | 170.79 | 173.94 | 210.31 | 231.31 | 253.69 | 282.43 |
| Interest coveragei | 0.78 | -0.07 | -0.59 | -1.59 | -1.43 | -1.22 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Titanium dioxide (TiO2) is the largest reported line at 80.65% of revenue, across 3 reported segments.
- The next-largest line, Zircon, is a distant second at 11.18% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Titanium dioxide (TiO2)80.65%
Zircon11.18%
Other products8.18%
Quote time 2026-10-08 10:10:30 · For reference only, not investment advice and not tailored to your situation.